Synthesized Antibiotics Market 2018: Global Opportunity Analysis and Industry Forecasts 2025 - PowerPoint PPT Presentation

About This Presentation

Synthesized Antibiotics Market 2018: Global Opportunity Analysis and Industry Forecasts 2025


Global Synthesized Antibiotics Market 2018 report Identify the latest market shares, developments and Growth Opportunities by the major market players. – PowerPoint PPT presentation

Number of Views:39


Transcript and Presenter's Notes

Title: Synthesized Antibiotics Market 2018: Global Opportunity Analysis and Industry Forecasts 2025

Global Synthesized Antibiotics Market
  • Drivers, Restraints, Potential Growth
    Opportunities, Vendor Competitive Landscape,
    Trends and Forecast 2018-2025

Single Use License US 4500
Request Sample
Global Synthesized Antibiotics Market
  • The global synthesized antibiotic market is
    anticipated to reach USD xx billion by 2025. The
    market is primarily driven by developing new
    approaches for antibiotics for treating bacterial
    infections. Moreover, growing incidences of
    infectious diseases like pneumonia, tuberculosis,
    HIV/AIDS, malaria, clubbed with the current crack
    between demand and supply of antibiotics are
    major factors for boosting global synthesized
    antibiotic market. Several biotech companies
    exhibit interest in global synthesized antibiotic
    industry research and development. Additionally,
    government legislation like Generating
    Antibiotics Incentives Now (GAIN) Act pushes
    research and development processes forward and
    creating opportunities for market players.
  • Rising Health Concerns with Antibiotic Resistance
  • Arrival of pathogenic bacteria resistant to most
    of the antibiotics is the rising health concern.
    The World Economic Forum, has discovered
    antibiotic resistance as greatest warning to
    human health. Global misuse of existing
    antibiotics and slow research on new antibiotics
    places global synthesized antibiotics industry at
    crisis. Innovation is in deficit as big
    pharmaceutical firms have halted antibactierial
    research and development, resulted in steep
    decline in launch of new antibacterials in last
    three decades. 
  • Browse the complete report on _at_

Global Synthesized Antibiotics Market
  •  With the ease of international travel, infection
    instigated by multidrug-resistant Gram-negative
    bacteria has become a challenge to treat.
    Infections such as pneumonia, tuberculosis, and
    gonorrhea have become immune to these drugs. Due
    to the bacterial resistance, global synthesized
    antibiotic market share is steadily losing its
    efficacy and without replenishment of
    antibacterial agents, humans are susceptible to
    return in pre-antibiotic era.
  • Background of Global Synthesized Antibiotic
  • Antibiotics can be used in various forms each
    of which demands different manufacturing
    requirements. When infections are related to eye,
    ear or skin surface, an antibiotic is applied as
    a cream or ointment. If internal infection
    occurs, antibiotic is swallowed or injected into
    blood veins. In all these cases, antibiotic gets
    distributed throughout the body.
  • Synthesized antibiotic differ in chemical
    structure. Hence, differ in the way they cure
    infections. Certain antibiotics destroy
    bacterias cell structure, sometimes, by
    weakening the cell walls which causes them to
    burst and other method causes the bacterial cells
    to leak by destroying their cell membranes.
  • At times, antibiotics like tetracycline and
    erythromycin kill the bacteria by interfering
    their metabolism with protein synthesis.
    Antibiotics, such as trimethoprim or sulfonamide
    have a common blocking effect on cell metabolism.

Global Synthesized Antibiotics Market
  • When development of antibiotic gets
    commercialized, it becomes a long and a costly
    proposal. At initial stage, basic research of
    organism which produce antibiotic compounds is
    done. When one organism is found, it is tested
    against various infectious bacteria. At later
    stages, to grow this species on large scale and
    for approval stages, Food and Drug Administration
    (FDA) is contacted, which is a lengthy and
    time-consuming process. For new antibiotic to
    pass economic feasibility, manufacturers of this
    industry should be able to get a high yield of
    global synthesized antibiotic market share from
    drug fermentation process.
  • Monoclonal and Other Antibodies Expected to
    Exhibit Significant Growth
  • The antibiotics segment which consists
    imidazoles, tetracyclines and lincosamides, and
    monoclonal antibodies had higher involvement in
    global synthesized antibiotic market share in the
    past and is expected to have a lucrative growth
    rate in the upcoming years.
  • Individuals who take higher amounts of antibiotic
    are vulnerable to antibiotic resistance, bodies
    of these individuals preferably require
    monoclonal antibodies to fight against the
  • Increasing cases of urinary tract infections
    (UTI), blood stream infections and pneumonia have
    fostered the usage of carbapenems antibiotics.

Global Synthesized Antibiotics Market
  • Regional Overview of Global synthesized
    antibiotic market
  • With a huge population, Asia Pacific is highly
    prevalent to regulation reforms, infectious
    diseases and higher use of generic medicine.
    Latin America with greater advancements in
    pharmaceutical sector is projected to
    extraordinary growth of global Synthesized
    Antibiotics Market.
  • Like tuberculosis, highest prevalence of the
    pneumonia is known to be in the Sub-Saharan and
    South Asian regions. Antibiotic treatment is
    accessible to one third of the infected
    population, thereby growing the disease burden.
  • Insightful Research for Future
  • A game changing synthesized antibiotic is
    identified which can destroy superbugs which has
    resistant pathogens such as VRE and MRSA. The
    breakthrough is major step in developing a drug
    based on teixobactin a natural antibiotic found
    from soil samples by US scientists. These
    scientists are able to fragment synthesized
    teixobactin into simplified forms which can also
    be used to treat the bacterial infection of mice.
  • Purchase a single user copy of the global
    Synthesized Antibiotics market report _at_

About Us
  • Adroit Market Research is an India-based business
    analytics and consulting company. Our target
    audience is a wide range of corporations,
    manufacturing companies, product/technology
    development institutions and industry
    associations that require understanding of a
    markets size, key trends, participants and
    future outlook of an industry. We intend to
    become our clients knowledge partner and provide
    them with valuable market insights to help create
    opportunities that increase their revenues. We
    follow a code Explore, Learn and Transform. At
    our core, we are curious people who love to
    identify and understand industry patterns, create
    an insightful study around our findings and churn
    out money-making roadmaps. Our analysts have
    tracked high growth markets in chemicals
    materials, healthcare pharmaceuticals,
    semiconductor electronics, energy power, food
    retail, consumer goods, technology, and
    machinery equipment sectors across the world to
    identify new opportunities, potential customers,
    prepare go-to-market (GTM) strategies, identify
    segments for revenue growth for companies, and
    many more.
  • US Headquarters3131 McKinney Ave Ste 600
    Dallas, TX 75204 ,U.S.A 
  • Phone 1 (214) 884-6068
  • Email
Write a Comment
User Comments (0)